HomeCompany NewsUS FDA approves Urogen's bladder cancer drug Company NewsHealthIsraelMiddle EastN2:BIODRGN2:CNCERN2:HECAN2:MEDREGN2:MRCHN2:PHMRN2:PUBLsubj:04002006subj:04016000subj:07000000subj:07001004subj:07013000subj:13019000 US FDA approves Urogen’s bladder cancer drug June 12, 2025 0 66 Share FacebookTwitterPinterestWhatsApp Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday. (Reporting by Padmanabhan Ananthan and Kamal Choudhury in Bengaluru; Editing by Leroy Leo) Hi, I'm Reuters Share FacebookTwitterPinterestWhatsApp Previous articleUS sues New York over law blocking immigration enforcement near courtNext articleTunisia sentences prominent opposition figure Abir Moussi to two years in prison RELATED ARTICLES America Police hold person of interest after Brown University shooting leaves two dead December 14, 2025 Asia World reacts to deadly shooting at Australia’s Bondi Beach December 14, 2025 Emergency Israeli Supreme Court rules against government’s dismissal of attorney general December 14, 2025 Most Popular Police hold person of interest after Brown University shooting leaves two dead December 14, 2025 World reacts to deadly shooting at Australia’s Bondi Beach December 14, 2025 Israeli Supreme Court rules against government’s dismissal of attorney general December 14, 2025 Chile votes in presidential race expected to lurch country to the right December 14, 2025 Ukraine’s Zelenskiy ditches NATO ambition ahead of peace talks December 14, 2025 Hong Kong’s last opposition party votes to disband under China pressure December 14, 2025 Load more